{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:09:56Z","timestamp":1792523396756,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T00:00:00Z","timestamp":1316390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T00:00:00Z","timestamp":1316390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,5,3]]},"DOI":"10.1038\/onc.2011.417","type":"journal-article","created":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T11:01:47Z","timestamp":1316430107000},"page":"2283-2297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Non-canonical HIF-2\u03b1 function drives autonomous breast cancer cell growth via an AREG\u2013EGFR\/ErbB4 autocrine loop"],"prefix":"10.1038","volume":"31","author":[{"given":"D P","family":"Stiehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Bordoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Abreu-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Wollenick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Schraml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Gradin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Poellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R H","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,19]]},"reference":[{"key":"BFonc2011417_CR1","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1158\/0008-5472.CAN-05-3345","volume":"66","author":"O Aprelikova","year":"2006","unstructured":"Aprelikova O, Wood M, Tackett S, Chandramouli GV, Barrett JC . (2006). Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res 66: 5641\u20135647.","journal-title":"Cancer Res"},{"key":"BFonc2011417_CR2","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1158\/0008-5472.CAN-08-1461","volume":"68","author":"S Banerjee","year":"2008","unstructured":"Banerjee S, Dhar G, Haque I, Kambhampati S, Mehta S, Sengupta K et al. (2008). CCN5\/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells. Cancer Res 68: 7606\u20137612.","journal-title":"Cancer Res"},{"key":"BFonc2011417_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrc2540","volume":"8","author":"JA Bertout","year":"2008","unstructured":"Bertout JA, Patel SA, Simon MC . (2008). The impact of O2 availability on human cancer. Nat Rev Cancer 8: 967\u2013975.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011417_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/onc.2010.433","volume":"30","author":"MR Bordoli","year":"2011","unstructured":"Bordoli MR, Stiehl DP, Borsig L, Kristiansen G, Hausladen S, Schraml P et al. (2011). Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis. Oncogene 30: 548\u2013560.","journal-title":"Oncogene"},{"key":"BFonc2011417_CR5","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1256804","volume":"18","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E et al. (2004). Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev 18: 2893\u20132904.","journal-title":"Genes Dev"},{"key":"BFonc2011417_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1101\/gad.1399906","volume":"20","author":"KL Covello","year":"2006","unstructured":"Covello KL, Kehler J, Yu H, Gordan JD, Arsham AM, Hu CJ et al. (2006). HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 20: 557\u2013570.","journal-title":"Genes Dev"},{"key":"BFonc2011417_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00424-005-1413-7","volume":"450","author":"EP Cummins","year":"2005","unstructured":"Cummins EP, Taylor CT . (2005). Hypoxia-responsive transcription factors. Pflugers Arch 450: 363\u2013371.","journal-title":"Pflugers Arch"},{"key":"BFonc2011417_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc2397","volume":"8","author":"MW Dewhirst","year":"2008","unstructured":"Dewhirst MW, Cao Y, Moeller B . (2008). Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8: 425\u2013437.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011417_CR9","doi-asserted-by":"publisher","first-page":"7520","DOI":"10.1074\/jbc.M211298200","volume":"278","author":"G Elvert","year":"2003","unstructured":"Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S, Acker T et al. (2003). Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 278: 7520\u20137530.","journal-title":"J Biol Chem"},{"key":"BFonc2011417_CR10","doi-asserted-by":"publisher","first-page":"15215","DOI":"10.1074\/jbc.M511408200","volume":"281","author":"GP Elvidge","year":"2006","unstructured":"Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, Gleadle JM . (2006). Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 281: 15215\u201315226.","journal-title":"J Biol Chem"},{"key":"BFonc2011417_CR11","doi-asserted-by":"publisher","first-page":"21306","DOI":"10.1073\/pnas.0906432106","volume":"106","author":"A Franovic","year":"2009","unstructured":"Franovic A, Holterman CE, Payette J, Lee S . (2009). Human cancers converge at the HIF-2alpha oncogenic axis. Proc Natl Acad Sci USA 106: 21306\u201321311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011417_CR12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1128\/MCB.01335-07","volume":"28","author":"A Fritah","year":"2008","unstructured":"Fritah A, Saucier C, De Wever O, Bracke M, Bieche I, Lidereau R et al. (2008). Role of WISP-2\/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells. Mol Cell Biol 28: 1114\u20131123.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011417_CR13","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","volume":"69","author":"RA Gatenby","year":"2009","unstructured":"Gatenby RA, Silva AS, Gillies RJ, Frieden BR . (2009). Adaptive therapy. Cancer Res 69: 4894\u20134903.","journal-title":"Cancer Res"},{"key":"BFonc2011417_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/sj.bjc.6603922","volume":"97","author":"RA Gatenby","year":"2007","unstructured":"Gatenby RA, Smallbone K, Maini PK, Rose F, Averill J, Nagle RB et al. (2007). Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer 97: 646\u2013653.","journal-title":"Br J Cancer"},{"key":"BFonc2011417_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ccr.2007.02.006","volume":"11","author":"JD Gordan","year":"2007","unstructured":"Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC . (2007). HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11: 335\u2013347.","journal-title":"Cancer Cell"},{"key":"BFonc2011417_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ccr.2008.10.016","volume":"14","author":"JD Gordan","year":"2008","unstructured":"Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE et al. (2008). HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 14: 435\u2013446.","journal-title":"Cancer Cell"},{"key":"BFonc2011417_CR17","doi-asserted-by":"publisher","first-page":"9212","DOI":"10.1158\/0008-5472.CAN-08-1135","volume":"68","author":"K Helczynska","year":"2008","unstructured":"Helczynska K, Larsson AM, Holmquist Mengelbier L, Bridges E, Fredlund E, Borgquist S et al. (2008). Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res 68: 9212\u20139220.","journal-title":"Cancer Res"},{"key":"BFonc2011417_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ccr.2006.08.026","volume":"10","author":"L Holmquist-Mengelbier","year":"2006","unstructured":"Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H et al. (2006). Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10: 413\u2013423.","journal-title":"Cancer Cell"},{"key":"BFonc2011417_CR19","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1091\/mbc.e06-05-0419","volume":"18","author":"CJ Hu","year":"2007","unstructured":"Hu CJ, Sataur A, Wang L, Chen H, Simon MC . (2007). The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell 18: 4528\u20134542.","journal-title":"Mol Biol Cell"},{"key":"BFonc2011417_CR20","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","volume":"23","author":"CJ Hu","year":"2003","unstructured":"Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC . (2003). Differential roles of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) and HIF-2\u03b1 in hypoxic gene regulation. Mol Cell Biol 23: 9361\u20139374.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011417_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1101\/gad.12.2.149","volume":"12","author":"NV Iyer","year":"1998","unstructured":"Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH et al. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1\u03b1. Genes Dev 12: 149\u2013162.","journal-title":"Genes Dev"},{"key":"BFonc2011417_CR22","doi-asserted-by":"publisher","first-page":"e6146","DOI":"10.1371\/journal.pone.0006146","volume":"4","author":"J Kao","year":"2009","unstructured":"Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J et al. (2009). Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 4: e6146.","journal-title":"PLoS One"},{"key":"BFonc2011417_CR23","doi-asserted-by":"publisher","first-page":"16278","DOI":"10.1074\/jbc.M700215200","volume":"282","author":"HS Kim","year":"2007","unstructured":"Kim HS, Kim MS, Hancock AL, Harper JC, Park JY, Poy G et al. (2007). Identification of novel Wilms\u2019 tumor suppressor gene target genes implicated in kidney development. J Biol Chem 282: 16278\u201316287.","journal-title":"J Biol Chem"},{"key":"BFonc2011417_CR24","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1172\/JCI38443","volume":"119","author":"WY Kim","year":"2009","unstructured":"Kim WY, Perera S, Zhou B, Carretero J, Yeh JJ, Heathcote SA et al. (2009). HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice. J Clin Invest 119: 2160\u20132170.","journal-title":"J Clin Invest"},{"key":"BFonc2011417_CR25","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/sj.bjc.6603675","volume":"96","author":"KW Lau","year":"2007","unstructured":"Lau KW, Tian YM, Raval RR, Ratcliffe PJ, Pugh CW . (2007). Target gene selectivity of hypoxia-inducible factor-alpha in renal cancer cells is conveyed by post-DNA-binding mechanisms. Br J Cancer 96: 1284\u20131292.","journal-title":"Br J Cancer"},{"key":"BFonc2011417_CR26","doi-asserted-by":"publisher","first-page":"7480","DOI":"10.1038\/sj.onc.1210566","volume":"26","author":"A Le Bras","year":"2007","unstructured":"Le Bras A, Lionneton F, Mattot V, Lelievre E, Caetano B, Spruyt N et al. (2007). HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites. Oncogene 26: 7480\u20137489.","journal-title":"Oncogene"},{"key":"BFonc2011417_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0092-8674(00)80053-7","volume":"98","author":"SB Lee","year":"1999","unstructured":"Lee SB, Huang K, Palmer R, Truong VB, Herzlinger D, Kolquist KA et al. (1999). The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 98: 663\u2013673.","journal-title":"Cell"},{"key":"BFonc2011417_CR28","doi-asserted-by":"publisher","first-page":"14004","DOI":"10.1073\/pnas.0901194106","volume":"106","author":"S Lehmann","year":"2009","unstructured":"Lehmann S, Stiehl DP, Honer M, Dominietto M, Keist R, Kotevic I et al. (2009). Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events. Proc Natl Acad Sci USA 106: 14004\u201314009.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011417_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1158\/0008-5472.CAN-06-2701","volume":"67","author":"D Liao","year":"2007","unstructured":"Liao D, Corle C, Seagroves TN, Johnson RS . (2007). Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res 67: 563\u2013572.","journal-title":"Cancer Res"},{"key":"BFonc2011417_CR30","first-page":"921","volume":"61","author":"DM Loeb","year":"2001","unstructured":"Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L et al. (2001). Wilms\u2019 tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 61: 921\u2013925.","journal-title":"Cancer Res"},{"key":"BFonc2011417_CR31","doi-asserted-by":"publisher","first-page":"14182","DOI":"10.1073\/pnas.1001296107","volume":"107","author":"J Mazumdar","year":"2010","unstructured":"Mazumdar J, Hickey MM, Pant DK, Durham AC, Sweet-Cordero A, Vachani A et al. (2010). HIF-2alpha deletion promotes Kras-driven lung tumor development. Proc Natl Acad Sci USA 107: 14182\u201314187.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011417_CR32","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1128\/MCB.00331-09","volume":"29","author":"YA Minamishima","year":"2009","unstructured":"Minamishima YA, Moslehi J, Padera RF, Bronson RT, Liao R, Kaelin Jr WG . (2009). A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol Cell Biol 29: 5729\u20135741.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011417_CR33","doi-asserted-by":"publisher","first-page":"16767","DOI":"10.1074\/jbc.M901790200","volume":"284","author":"DR Mole","year":"2009","unstructured":"Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, Ragoussis J et al. (2009). Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem 284: 16767\u201316775.","journal-title":"J Biol Chem"},{"key":"BFonc2011417_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","volume":"10","author":"RM Neve","year":"2006","unstructured":"Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T et al. (2006). A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515\u2013527.","journal-title":"Cancer Cell"},{"key":"BFonc2011417_CR35","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z et al. (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10: 5367\u20135374.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011417_CR36","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1128\/MCB.23.14.4959-4971.2003","volume":"23","author":"SK Park","year":"2003","unstructured":"Park SK, Dadak AM, Haase VH, Fontana L, Giaccia AJ, Johnson RS . (2003). Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Mol Cell Biol 23: 4959\u20134971.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011417_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/cdd.2008.17","volume":"15","author":"SA Patel","year":"2008","unstructured":"Patel SA, Simon MC . (2008). Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ 15: 628\u2013634.","journal-title":"Cell Death Differ"},{"key":"BFonc2011417_CR38","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. (2000). Molecular portraits of human breast tumours. Nature 406: 747\u2013752.","journal-title":"Nature"},{"key":"BFonc2011417_CR39","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","volume":"25","author":"RR Raval","year":"2005","unstructured":"Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL et al. (2005). Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel\u2013Lindau-associated renal cell carcinoma. Mol Cell Biol 25: 5675\u20135686.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011417_CR40","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm.2146","volume":"16","author":"T Saito","year":"2010","unstructured":"Saito T, Fukai A, Mabuchi A, Ikeda T, Yano F, Ohba S et al. (2010). Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 16: 678\u2013686.","journal-title":"Nat Med"},{"key":"BFonc2011417_CR41","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/onc.2009.441","volume":"29","author":"GL Semenza","year":"2010","unstructured":"Semenza GL . (2010). Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29: 625\u2013634.","journal-title":"Oncogene"},{"key":"BFonc2011417_CR42","doi-asserted-by":"crossref","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","volume":"269","author":"GL Semenza","year":"1994","unstructured":"Semenza GL, Roth PH, Fang HM, Wang GL . (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269: 23757\u201323763.","journal-title":"J Biol Chem"},{"key":"BFonc2011417_CR43","first-page":"6130","volume":"63","author":"HM Sowter","year":"2003","unstructured":"Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL . (2003). Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 63: 6130\u20136134.","journal-title":"Cancer Res"},{"key":"BFonc2011417_CR44","doi-asserted-by":"publisher","first-page":"23482","DOI":"10.1074\/jbc.M601719200","volume":"281","author":"DP Stiehl","year":"2006","unstructured":"Stiehl DP, Wirthner R, Koditz J, Spielmann P, Camenisch G, Wenger RH . (2006). Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J Biol Chem 281: 23482\u201323491.","journal-title":"J Biol Chem"},{"key":"BFonc2011417_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1023\/A:1025476722493","volume":"81","author":"L Tomes","year":"2003","unstructured":"Tomes L, Emberley E, Niu Y, Troup S, Pastorek J, Strange K et al. (2003). Necrosis and hypoxia in invasive breast carcinoma. Breast Cancer Res Treat 81: 61\u201369.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2011417_CR46","doi-asserted-by":"publisher","first-page":"e9641","DOI":"10.1371\/journal.pone.0009641","volume":"5","author":"V Wang","year":"2010","unstructured":"Wang V, Davis DA, Veeranna RP, Haque M, Yarchoan R . (2010). Characterization of the activation of protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1) by hypoxia inducible factor-2 alpha. PLoS One 5: e9641.","journal-title":"PLoS One"},{"key":"BFonc2011417_CR47","doi-asserted-by":"crossref","first-page":"re12","DOI":"10.1126\/stke.3062005re12","volume":"2005","author":"RH Wenger","year":"2005","unstructured":"Wenger RH, Stiehl DP, Camenisch G . (2005). Integration of oxygen signaling at the consensus HRE. Sci STKE 2005: re12.","journal-title":"Sci STKE"},{"key":"BFonc2011417_CR48","first-page":"7075","volume":"60","author":"CC Wykoff","year":"2000","unstructured":"Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A et al. (2000). Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60: 7075\u20137083.","journal-title":"Cancer Res"},{"key":"BFonc2011417_CR49","doi-asserted-by":"publisher","first-page":"18926","DOI":"10.1074\/jbc.M709133200","volume":"283","author":"T Yamashita","year":"2008","unstructured":"Yamashita T, Ohneda K, Nagano M, Miyoshi C, Kaneko N, Miwa Y et al. (2008). Hypoxia-inducible transcription factor-2alpha in endothelial cells regulates tumor neovascularization through activation of ephrin A1. J Biol Chem 283: 18926\u201318936.","journal-title":"J Biol Chem"},{"key":"BFonc2011417_CR50","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1128\/MCB.01514-06","volume":"27","author":"Q Yan","year":"2007","unstructured":"Yan Q, Bartz S, Mao M, Li L, Kaelin Jr WG . (2007). The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo. Mol Cell Biol 27: 2092\u20132102.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011417_CR51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nm.2153","volume":"16","author":"S Yang","year":"2010","unstructured":"Yang S, Kim J, Ryu JH, Oh H, Chun CH, Kim BJ et al. (2010). Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 16: 687\u2013693.","journal-title":"Nat Med"},{"key":"BFonc2011417_CR52","doi-asserted-by":"publisher","first-page":"35035","DOI":"10.1074\/jbc.M707557200","volume":"282","author":"P Yu","year":"2007","unstructured":"Yu P, Kodadek T . (2007). Dynamics of the hypoxia-inducible factor-1-vascular endothelial growth factor promoter complex. J Biol Chem 282: 35035\u201335045.","journal-title":"J Biol Chem"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011417","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:21:40Z","timestamp":1647886900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,19]]},"references-count":52,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,5,3]]}},"alternative-id":["BFonc2011417"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.417","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,19]]},"assertion":[{"value":"13 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}